S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:AVGR

Avinger (AVGR) Stock Price, News & Analysis

$3.10
+0.16 (+5.44%)
(As of 03/28/2024 ET)
Today's Range
$2.93
$3.27
50-Day Range
$2.51
$5.34
52-Week Range
$2.50
$18.00
Volume
31,740 shs
Average Volume
54,533 shs
Market Capitalization
$5.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Avinger MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
61.3% Upside
$5.00 Price Target
Short Interest
Bearish
5.64% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.57mentions of Avinger in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.08) to ($1.35) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.62 out of 5 stars

AVGR stock logo

About Avinger Stock (NASDAQ:AVGR)

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

AVGR Stock Price History

AVGR Stock News Headlines

Avinger, Inc. (NASDAQ:AVGR) Short Interest Update
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com
Avinger's (AVGR) Buy Rating Reaffirmed at HC Wainwright
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Avinger, Inc.
Shanetia S. Avinger
Avinger, Inc.: Avinger Reports Third Quarter 2023 Results
Avinger Reports Third Quarter 2023 Results
Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates
Avinger Earnings Preview
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
3/28/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:AVGR
Employees
68
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+61.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-18,320,000.00
Net Margins
-239.41%
Pretax Margin
-239.41%

Debt

Sales & Book Value

Annual Sales
$7.65 million
Book Value
($4.53) per share

Miscellaneous

Free Float
1,629,000
Market Cap
$5.27 million
Optionable
Not Optionable
Beta
1.30
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Jeffrey M. Soinski (Age 62)
    President, CEO & Director
    Comp: $616.79k
  • Mr. Nabeel P. Subainati (Age 40)
    VP of Finance, Principal Financial Officer & Accounting Officer
    Comp: $347.58k
  • Mr. Himanshu N. Patel (Age 64)
    Chief Technology Officer
    Comp: $430.08k
  • Mr. Keith Schaefer
    Chief Operating Officer
  • Mr. Corey Gibbs
    Vice President of Sales
  • Dr. Jaafer Golzar FACC
    M.D., Chief Medical Officer

AVGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

What is Avinger's stock price target for 2024?

1 brokerages have issued 12-month price objectives for Avinger's stock. Their AVGR share price targets range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 61.3% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2024?

Avinger's stock was trading at $2.71 on January 1st, 2024. Since then, AVGR shares have increased by 14.4% and is now trading at $3.0990.
View the best growth stocks for 2024 here
.

Are investors shorting Avinger?

Avinger saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 89,600 shares, an increase of 281.3% from the February 29th total of 23,500 shares. Based on an average trading volume of 52,500 shares, the days-to-cover ratio is currently 1.7 days. Approximately 5.6% of the company's shares are short sold.
View Avinger's Short Interest
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) issued its quarterly earnings data on Thursday, November, 11th. The medical device company reported ($18.00) EPS for the quarter, beating analysts' consensus estimates of ($21.00) by $3.00. The medical device company had revenue of $2.37 million for the quarter, compared to analyst estimates of $2.52 million. Avinger had a negative trailing twelve-month return on equity of 6,767.92% and a negative net margin of 239.41%. During the same quarter last year, the business posted ($24.00) earnings per share.

When did Avinger's stock split?

Shares of Avinger reverse split before market open on Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

Avinger (AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AVGR) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners